B Asselain

发表

[The Cox model: limitations and extensions].

C Quantin, B Asselain, T Moreau, 1990, Revue d'epidemiologie et de sante publique.

Discrete strategies of cancer post-treatment surveillance. Estimation and optimization problems.

A D Tsodikov, B Asselain, A Fourque, 1995, Biometrics.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.

B Asselain, A Fourquet, C. Genestie, 1998, Anticancer research.

Five-year survival for lung cancer patients managed in general hospitals.

B Asselain, B. Asselain, M. Zureik, 2011, Revue des maladies respiratoires.

Mammographic features of 455 invasive lobular carcinomas.

B Asselain, S Neuenschwander, B. Asselain, 1992, Radiology.

Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.

B Asselain, A Fourquet, A. Rahmouni, 1993, Radiology.

Multi-state Markov models in cancer screening evaluation: a brief review and case study

D Eilstein, B Asselain, M Colonna, 2010, Statistical methods in medical research.

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

B Asselain, P Broët, B. Asselain, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A distribution of tumor size at detection: an application to breast cancer data.

A D Tsodikov, B Asselain, A Y Yakovlev, 1997, Biometrics.

A Semiparametric Approach for the Two‐Sample Comparison of Survival Times with Long‐Term Survivors

B Asselain, J Lellouch, P Broët, 2001, Biometrics.

A regression survival model for testing the proportional hazards hypothesis.

C Quantin, B Asselain, J Lellouch, 1996, Biometrics.